SHADEFAI ZSALINN GOLDSMITH
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ROCHESTER, NY NPI 1760622807
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NY GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$1,199.21
- Category: General Payments
- Program years: PY2023–2024
- Record count: 12
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $743.21 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $643.22 | 6 |
| Education | $99.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $359.97 | 3 |
| Amgen Inc. | $283.25 | 3 |
| Janssen Biotech, Inc. | $99.99 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078466452 | Janssen Biotech, Inc. | $99.99 | 05/28/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1116207588 | GlaxoSmithKline, LLC. | $124.99 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116423261 | GlaxoSmithKline, LLC. | $109.99 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116606676 | GlaxoSmithKline, LLC. | $124.99 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117564096 | Amgen Inc. | $99.66 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117564098 | Amgen Inc. | $126.12 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117564100 | Amgen Inc. | $57.47 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.